Jazz Pharmaceuticals to Report 2018 Q4 and Full Year Financial Results on February 26, 2019

Jazz Pharmaceuticals plc announced that it will report its 2018 fourth quarter and full year financial results on Tuesday, February 26, 2019, after the close of the financial markets.  Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EST/9:30 p.m. GMT to discuss fourth quarter and full year 2018 financial results and provide a business and financial update and guidance for 2019 financial results. Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website.  Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.  A replay of the webcast will be archived on the website for at least one week.

Audio webcast/conference call: U.S. Dial-In Number:  +1 855 353 7924; International Dial-In Number: +1 503 343 6056; Passcode: 7095707

A replay of the conference call will be available through March 5, 2019 and accessible through one of the following telephone numbers, using the passcode below:

• Replay U.S. Dial-In Number: +1 855 859 2056
• Replay International Dial-In Number:  +1 404 537 3406
• Passcode: 7095707 – Medical Buyer Bureau